The average one-year price target for PDS Biotechnology (NASDAQCM:PDSB) has been revised to $4.25 / share. This is a decrease of 13.79% from the prior estimate of $4.93 dated August 25, 2026. These ...

Matica Biotechnology ("Matica Bio"), a Texas-based contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced a collaboration with Bondwell ...

Meroueh may have found a way to clean up steelmaking without driving up the price. Her new furnace turns iron ore into ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...

"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...

PDS Biotechnology (PDSB) said Monday it has raised about $11.3 million from an initial closing of a private financing, with Nant Capital leading the round. The company said it sold shares, pre-funded ...

The convergence of AI and biotechnology blurs boundaries and challenges existing regulations designed to consider technologies separately.

A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market. What Are Smart ...

Nautilus Biotechnology, Inc. ( NAUT ), a development-stage life sciences company focused on single-molecule proteomics, on Friday announced a peer-reviewed publication in Nature Methods demonstrating ...

China is simply building up its technological capabilities, strengthening its domestic industrial chains, and pursuing steady ...